Emerging evidence demonstrates that GACAT3 is remarkably upregulated in CRC, HCC, breast cancer, NSCLC, bladder cancer, and glioma but shows diverse expression in GC cell lines. This evidence concerns the gene GACAT3 and colorectal carcinoma.